HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism (original) (raw)

• Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. & Steitz, T.A. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783–1790 (1992).
  Article CAS PubMed Google Scholar
• Jacobo-Molina, A. et al. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90, 6320–6324 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Huang, H., Chopra, R., Verdine, G.L. & Harrison, S.C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669–1675 (1998).
  Article CAS PubMed Google Scholar
• Ren, J. & Stammers, D.K. Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase. Virus Res. 134, 157–170 (2008).
  Article CAS PubMed Google Scholar
• Tu, X. et al. Structural basis of HIV-1 resistance to AZT by excision. Nat. Struct. Mol. Biol. 17, 1202–1209 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Das, K. et al. Roles of conformational and positional adaptability in structure-based design of TMC125–R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J. Med. Chem. 47, 2550–2560 (2004).
  Article CAS PubMed Google Scholar
• Steitz, T.A. DNA polymerases: structural diversity and common mechanisms. J. Biol. Chem. 274, 17395–17398 (1999).
  Article CAS PubMed Google Scholar
• Sarafianos, S.G. et al. Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site. Chem. Biol. 6, R137–R146 (1999).
  Article CAS PubMed Google Scholar
• Rodgers, D.W. et al. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 1222–1226 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Hsiou, Y. et al. Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure 4, 853–860 (1996).
  Article CAS PubMed Google Scholar
• Rittinger, K., Divita, G. & Goody, R.S. Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc. Natl. Acad. Sci. USA 92, 8046–8049 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Spence, R.A., Kati, W.M., Anderson, K.S. & Johnson, K.A. Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science 267, 988–993 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Sluis-Cremer, N., Temiz, N.A. & Bahar, I. Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding. Curr. HIV Res. 2, 323–332 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Geitmann, M., Unge, T. & Danielson, U.H. Biosensor-based kinetic characterization of the interaction between HIV-1 reverse transcriptase and non-nucleoside inhibitors. J. Med. Chem. 49, 2367–2374 (2006).
  Article CAS PubMed Google Scholar
• Tachedjian, G., Orlova, M., Sarafianos, S.G., Arnold, E. & Goff, S.P. Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 98, 7188–7193 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Abbondanzieri, E.A. et al. Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453, 184–189 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, S., Abbondanzieri, E.A., Rausch, J.W., Le Grice, S.F. & Zhuang, X. Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates. Science 322, 1092–1097 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Peletskaya, E.N., Kogon, A.A., Tuske, S., Arnold, E. & Hughes, S.H. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA. J. Virol. 78, 3387–3397 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Xia, Q., Radzio, J., Anderson, K.S. & Sluis-Cremer, N. Probing nonnucleoside inhibitor-induced active-site distortion in HIV-1 reverse transcriptase by transient kinetic analyses. Protein Sci. 16, 1728–1737 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Ren, J. et al. High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat. Struct. Biol. 2, 293–302 (1995).
  Article CAS PubMed Google Scholar
• Das, K. et al. Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. J. Mol. Biol. 264, 1085–1100 (1996).
  Article CAS PubMed Google Scholar
• Meyer, P.R., Matsuura, S.E., Mian, A.M., So, A.G. & Scott, W.A. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol. Cell 4, 35–43 (1999).
  Article CAS PubMed Google Scholar
• Arion, D., Kaushik, N., McCormick, S., Borkow, G. & Parniak, M.A. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37, 15908–15917 (1998).
  Article CAS PubMed Google Scholar
• Gu, Z., Quan, Y., Li, Z., Arts, E.J. & Wainberg, M.A. Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays. J. Biol. Chem. 270, 31046–31051 (1995).
  Article CAS PubMed Google Scholar
• Mitsuya, H. et al. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA 82, 7096–7100 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Katz, R.A. & Skalka, A.M. The retroviral enzymes. Annu. Rev. Biochem. 63, 133–173 (1994).
  Article CAS PubMed Google Scholar
• Sarafianos, S.G. et al. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J. 20, 1449–1461 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Das, K. et al. Structural basis for the role of the K65R mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance. J. Biol. Chem. 284, 35092–35100 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lansdon, E.B. et al. Visualizing the molecular interactions of a nucleotide analog, GS-9148, with HIV-1 reverse transcriptase-DNA complex. J. Mol. Biol. 397, 967–978 (2010).
  Article CAS PubMed Google Scholar
• Tuske, S. et al. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat. Struct. Mol. Biol. 11, 469–474 (2004).
  Article CAS PubMed Google Scholar
• Mizrahi, V., Henrie, R.N., Marlier, J.F., Johnson, K.A. & Benkovic, S.J. Rate-limiting steps in the DNA polymerase I reaction pathway. Biochemistry 24, 4010–4018 (1985).
  Article CAS PubMed Google Scholar
• Beese, L.S., Derbyshire, V. & Steitz, T.A. Structure of DNA polymerase I Klenow fragment bound to duplex DNA. Science 260, 352–355 (1993).
  Article CAS PubMed Google Scholar
• Li, Y., Korolev, S. & Waksman, G. Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: structural basis for nucleotide incorporation. EMBO J. 17, 7514–7525 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Santoso, Y. et al. Conformational transitions in DNA polymerase I revealed by single-molecule FRET. Proc. Natl. Acad. Sci. USA 107, 715–720 (2010).
  Article CAS PubMed Google Scholar
• Obeid, S. et al. Replication through an abasic DNA lesion: structural basis for adenine selectivity. EMBO J. 29, 1738–1747 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Zahn, K.E., Belrhali, H., Wallace, S.S. & Doublie, S. Caught bending the A-rule: crystal structures of translesion DNA synthesis with a non-natural nucleotide. Biochemistry 46, 10551–10561 (2007).
  Article CAS PubMed Google Scholar
• Cai, H., Bloom, L.B., Eritja, R. & Goodman, M.F. Kinetics of deoxyribonucleotide insertion and extension at abasic template lesions in different sequence contexts using HIV-1 reverse transcriptase. J. Biol. Chem. 268, 23567–23572 (1993).
  CAS PubMed Google Scholar
• Joyce, C.M. & Benkovic, S.J. DNA polymerase fidelity: kinetics, structure, and checkpoints. Biochemistry 43, 14317–14324 (2004).
  Article CAS PubMed Google Scholar
• Molina, J.M. et al. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet 378, 238–246 (2011).
  Article CAS PubMed Google Scholar
• Carr, A. et al. A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group. AIDS 10, 635–641 (1996).
  Article CAS PubMed Google Scholar
• Odriozola, L. et al. Non-nucleoside inhibitors of HIV-1 reverse transcriptase inhibit phosphorolysis and resensitize the 3′-azido-3′-deoxythymidine (AZT)-resistant polymerase to AZT-5′-triphosphate. J. Biol. Chem. 278, 42710–42716 (2003).
  Article CAS PubMed Google Scholar
• Basavapathruni, A., Bailey, C.M. & Anderson, K.S. Defining a molecular mechanism of synergy between nucleoside and nonnucleoside AIDS drugs. J. Biol. Chem. 279, 6221–6224 (2004).
  Article CAS PubMed Google Scholar
• Selmi, B. et al. The Y181C substitution in 3′-azido-3′-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3′-azido-3′-deoxythymidine 5′-monophosphate-terminated primer. J. Biol. Chem. 278, 40464–40472 (2003).
  Article CAS PubMed Google Scholar
• Xu, H.T. et al. Compensation by the E138K mutation in HIV-1 reverse transcriptase for deficits in viral replication capacity and enzyme processivity associated with the M184I/V mutations. J. Virol. 85, 11300–11308 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Biswal, B.K. et al. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J. Biol. Chem. 280, 18202–18210 (2005).
  Article CAS PubMed Google Scholar
• Mukhopadhyay, J. et al. The RNA polymerase 'switch region' is a target for inhibitors. Cell 135, 295–307 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bauman, J.D. et al. Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res. 36, 5083–5092 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• DeStefano, J.J. et al. Characterization of an RNase H deficient mutant of human immunodeficiency virus-1 reverse transcriptase having an aspartate to asparagine change at position 498. Biochim. Biophys. Acta 1219, 380–388 (1994).
  Article CAS PubMed Google Scholar
• Hou, X., Wang, G., Gaffney, B.L. & Jones, R.A. Synthesis of guanosine and deoxyguanosine phosphoramidites with cross-linkable thioalkyl tethers for direct incorporation into RNA and DNA. Nucleosides Nucleotides Nucleic Acids 28, 1076–1094 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Sarafianos, S.G. et al. Trapping HIV-1 reverse transcriptase before and after translocation on DNA. J. Biol. Chem. 278, 16280–16288 (2003).
  Article CAS PubMed Google Scholar
• Otwinowski, Z. & Minor, W. DENZO and SCALEPACK. in International Tables for Crystallography Vol. F: Crystallography of Biological Macromolecules (Kluwer, Boston, 2001).
• Strong, M. et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 8060–8065 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Cowtan, K. 'dm': An automated procedure for phase improvement by density modification. in Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography Vol. 31, 34–38 (Daresbury Laboratory, Warrington, UK, 1994).
• Adams, P.D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
  Article PubMed Google Scholar